In The News
Test post after maintenance
Construction Test 7
Construction Test 6
Construction Test 5
Construction test article 2
Test – Racing Victoria planned agreement to ‘seriously breach’ competition laws, court hears
Construction test article 1
I’m afraid AI can’t do that: Law firms say smart tech uses limited
Holden dealers reject GM’s bleak alternate reality in class action
Lawyer’s defamation case fails serious harm test, judge finds

Biogen said Thursday it will pull its multiple sclerosis drug Zinbryta in Australia, nearly two weeks after the biotech company issued a worldwide withdrawal of the drug following reports of encephalitus in Europe.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

For information on rights and reprints, contact subscriptions@lawyerly.com.au